{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:54:59Z","timestamp":1779306899325,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00253-012-4632-9","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T06:38:15Z","timestamp":1355812695000},"page":"3855-3863","source":"Crossref","is-referenced-by-count":20,"title":["Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris"],"prefix":"10.1007","volume":"97","author":[{"given":"Lin","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqiu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"issue":"5","key":"4632_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2747","volume":"10","author":"A Beck","year":"2010","unstructured":"Beck A, Wurch T, Bailly B, Corvaia N (2010) Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 10(5):345\u2013352","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"4632_CR2","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1212\/WNL.0b013e3181c97ed3","volume":"74","author":"B Bielekova","year":"2010","unstructured":"Bielekova B, Becker BL (2010) Monoclonal antibodies in MS: mechanisms of action. Neurology 74(Suppl 1):S31\u2013S40","journal-title":"Neurology"},{"issue":"4877","key":"4632_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.3140379","volume":"242","author":"RE Bird","year":"1988","unstructured":"Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M (1988) Single-chain antigen-binding proteins. Science 242(4877):423\u2013426","journal-title":"Science"},{"issue":"6","key":"4632_CR4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1517\/14712598.2010.485187","volume":"10","author":"M Campara","year":"2010","unstructured":"Campara M, Tzvetanov IG, Oberholzer J (2010) Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation. Expert Opin Biol Ther 10(6):959\u2013969","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 3","key":"4632_CR5","first-page":"S82","volume":"17","author":"GL Colice","year":"2011","unstructured":"Colice GL (2011) Emerging therapeutic options for asthma. Am J Manage Care 17(Suppl 3):S82\u2013S89","journal-title":"Am J Manage Care"},{"issue":"4","key":"4632_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tibs.2009.11.005","volume":"35","author":"MJ Feige","year":"2010","unstructured":"Feige MJ, Hendershot LM, Buchner J (2010) How antibodies fold. Trends Biochem Sci 35(4):189\u2013198","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"4632_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.22339","volume":"69","author":"J Hao","year":"2011","unstructured":"Hao J, Campagnolo D, Liu R, Piao W, Shi S, Hu B, Xiang R, Zhou Q, Vollmer T, Van Kaer L, La Cava A, Shi FD (2011) Interleukin-2\/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann Neurol 69(4):721\u2013734","journal-title":"Ann Neurol"},{"issue":"3","key":"4632_CR8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2(3):214\u2013221","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4632_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-011-0941-5","volume":"94","author":"T Ishida","year":"2011","unstructured":"Ishida T, Ueda R (2011) Antibody therapy for adult T-cell leukemia-lymphoma. Int J Hematol 94(5):443\u2013452","journal-title":"Int J Hematol"},{"key":"4632_CR10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nprot.2008.213","volume":"4","author":"PP Jacobs","year":"2009","unstructured":"Jacobs PP, Geysens S, Vervecken W, Contreras R, Callewaert N (2009) Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protoc 4:58\u201370","journal-title":"Nat Protoc"},{"issue":"1","key":"4632_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11537830-000000000-00000","volume":"25","author":"E Kaneko","year":"2011","unstructured":"Kaneko E, Niwa R (2011) Optimizing therapeutic antibody function: progress with Fc domain engineering. BioDrugs 25(1):1\u201311","journal-title":"BioDrugs"},{"issue":"2","key":"4632_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00063030-200923020-00003","volume":"23","author":"RE Kontermann","year":"2009","unstructured":"Kontermann RE (2009) Strategies to extend plasma half-lives of recombinant antibodies. BioDrugs 23(2):93\u2013109","journal-title":"BioDrugs"},{"issue":"9","key":"4632_CR13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1349-7006.2009.01222.x","volume":"100","author":"T Kubota","year":"2009","unstructured":"Kubota T, Niwa R, Satoh M, Akinaga S, Shitara K, Hanai N (2009) Engineered therapeutic antibodies with improved effector functions. Cancer Sci 100(9):1566\u20131572","journal-title":"Cancer Sci"},{"issue":"2","key":"4632_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14728214.2011.537824","volume":"16","author":"T Larson","year":"2011","unstructured":"Larson T, Nussenblatt RB, Sen HN (2011) Emerging drugs for uveitis. Expert Opin Emerg Drugs 16(2):309\u2013322","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8","key":"4632_CR15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00259-010-1433-1","volume":"37","author":"EJ Lepin","year":"2010","unstructured":"Lepin EJ, Leyton JV, Zhou Y, Olafsen T, Salazar FB, McCabe KE, Hahm S, Marks JD, Reiter RE, Wu AM (2010) An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging 37(8):1529\u20131538","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"4632_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2011.10.008","volume":"142","author":"R Martin","year":"2012","unstructured":"Martin R (2012) Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis. Clin Immunol 142(1):9\u201314","journal-title":"Clin Immunol"},{"issue":"2","key":"4632_CR17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","volume":"185","author":"JF Martin","year":"2010","unstructured":"Martin JF, Perry JS, Jakhete NR, Wang X, Bielekova B (2010) An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells. J Immunol 185(2):1311\u20131320","journal-title":"J Immunol"},{"issue":"1","key":"4632_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1110\/ps.073134408","volume":"17","author":"A McAuley","year":"2008","unstructured":"McAuley A, Jacob J, Kolvenbach CG, Westland K, Lee HJ, Brych SR, Rehder D, Kleemann GR, Brems DN, Matsumura M (2008) Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain. Protein Sci 17(1):95\u2013106","journal-title":"Protein Sci"},{"issue":"10","key":"4632_CR19","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1517\/14712598.7.10.1583","volume":"7","author":"M Mottershead","year":"2007","unstructured":"Mottershead M, Neuberger J (2007) Daclizumab. Expert Opin Biol Ther 7(10):1583\u20131596","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"4632_CR20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2967\/jnumed.108.060426","volume":"50","author":"T Olafsen","year":"2009","unstructured":"Olafsen T, Betting D, Kenanova VE, Salazar FB, Clarke P, Said J, Raubitschek AA, Timmerman JM, Wu AM (2009) Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas. J Nucl Med 50(9):1500\u20131508","journal-title":"J Nucl Med"},{"issue":"5","key":"4632_CR21","doi-asserted-by":"crossref","first-page":"e37242","DOI":"10.1371\/journal.pone.0037242","volume":"7","author":"T R\u00fclker","year":"2012","unstructured":"R\u00fclker T, Vo\u00df L, Thullier P, O'Brien LM, Pelat T, Perkins SD, Langermann C, Schirrmann T, D\u00fcbel S, Marschall HJ, Hust M, H\u00fclseweh B (2012) Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One 7(5):e37242","journal-title":"PLoS One"},{"issue":"2","key":"4632_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.it.2003.12.001","volume":"25","author":"L Sanz","year":"2004","unstructured":"Sanz L, Blanco B, Alvarez-Vallina L (2004) Antibodies and gene therapy: teaching old \u2018magic bullets\u2019 new tricks. Trends Immunol 25(2):85\u201391","journal-title":"Trends Immunol"},{"issue":"1","key":"4632_CR23","doi-asserted-by":"crossref","first-page":"e15921","DOI":"10.1371\/journal.pone.0015921","volume":"6","author":"H Thie","year":"2011","unstructured":"Thie H, Toleikis L, Li J, von Wasielewski R, Bastert G, Schirrmann T, Esteves IT, Behrens CK, Fournes B, Fournier N, de Romeuf C, Hust M, D\u00fcbel S (2011) Rise and fall of an anti-MUC1 specific antibody. PLoS One 6(1):e15921","journal-title":"PLoS One"},{"issue":"1","key":"4632_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-006-9060-0","volume":"27","author":"TA Waldmann","year":"2007","unstructured":"Waldmann TA (2007) Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey. J Clin Immunol 27(1):1\u201318","journal-title":"J Clin Immunol"},{"issue":"1","key":"4632_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00253-008-1568-1","volume":"81","author":"L Wan","year":"2008","unstructured":"Wan L, Cai H, Yang H, Lu Y, Li Y, Li X, Li S, Zhang J, Li Y, Cheng J, Lu X (2008) High-level expression of a functional humanized single-chain variable fragment antibody against CD25 in Pichia pastoris. Appl Microbiol Biotechnol 81(1):33\u201341","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"4632_CR26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00253-011-3277-4","volume":"91","author":"L Wan","year":"2011","unstructured":"Wan L, Zhu S, Li Y, Liu S, Yang H, Li S, Li Y, Cheng J, Lu X (2011) Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris. Appl Microbiol Biotechnol 91(3):543\u2013551","journal-title":"Appl Microbiol Biotechnol"},{"issue":"24","key":"4632_CR27","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1158\/0008-5472.CAN-10-1134","volume":"71","author":"X Wang","year":"2011","unstructured":"Wang X, Katayama A, Wang Y, Yu L, Favoino E, Sakakura K, Favole A, Tsuchikawa T, Silver S, Watkins SC, Kageshita T, Ferrone S (2011) Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4. Cancer Res 71(24):7410\u20137422","journal-title":"Cancer Res"},{"issue":"5","key":"4632_CR28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nm.2365","volume":"17","author":"SC Wuest","year":"2011","unstructured":"Wuest SC, Edwan JH, Martin JF, Han S, Perry JS, Cartagena CM, Matsuura E, Maric D, Waldmann TA, Bielekova B (2011) A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med 17(5):604\u2013609","journal-title":"Nat Med"},{"issue":"4","key":"4632_CR29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jb\/mvs007","volume":"151","author":"N Yuasa","year":"2012","unstructured":"Yuasa N, Ogawa H, Koizumi T, Tsukamoto K, Matsumoto-Takasaki A, Asanuma H, Nakada H, Fujita-Yamaguchi Y (2012) Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody. J Biochem 151(4):371\u2013381","journal-title":"J Biochem"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-012-4632-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4632-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:20:06Z","timestamp":1558711206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-012-4632-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["4632"],"URL":"https:\/\/doi.org\/10.1007\/s00253-012-4632-9","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}